Skip to main content
SpringerLink
Log in

Structural organization of binding determinants in the molecule of insulin-like growth factor-I (IGF-I)

  • Problem Papers
  • Published:
Journal of Evolutionary Biochemistry and Physiology Aims and scope Submit manuscript

Abstract

Insulin-like growth factor I (IGF-I) is a peptide related to insulin and IGF-II. These three related peptides produce similar biological effects, but each of them has its irreplaceable physiological significance in the organism. Multisided functional role of IGF-I in the organism is due to its unique binding properties. Specifically, but with different degree of affinity, it is able to interact with three receptors (IGF-I-receptor, insulin receptor, and IGF-II-receptor) and six binding proteins (IGFBP 1–6). To interact with each of the above objects, the IGF-I molecule contains individual structural determinants—binding domains (BD) providing strict specificity of interaction with them. Responsible for the IGF-I biological effects and binding with IGF-I-receptor is α-domain, for binding with insulin receptor—β-, EGF-II—γ-, while with all BP—δ-BD, respectively. Results of experimental study of binding domains not always can be estimated unanimously. The proposed by the author system of criteria for evaluation of changes in affinity of the IGF-I analogies allows unraveling the structural organization of each of the domains and tracing dependence on it of the peptide affinity to the particular object. This work considers composition, organization, and principle of formation of affinity of three binding IGF-I domains (α-, γ-, and δ-BD). The α-domain includes three tyrosines from three different molecule sites (B-24, C-31, and A-60) disposed spatially in the direct vicinity on its one surface. The β-domain also is considered as the domain participating in the high-affinity interaction; by composition and location in molecule it principally differs from α-BD, with the structural organization that so far has not been deciphered. Analyzed in detail is the key significance of the N-terminal site of the B-chain—the linear site of the domain—for binding of IGF-I with BP, functional heterogeneity of its constituent residues, and the characteristic principle of formation of affinity to BP. Analysis indicates a probability of the second δ-BD, quite possibly not the only one, and a high sensitivity of the domain to configuration of the IGH-I molecule surface. Structural organization and peculiarities of formation of affinity in the γ-domain are studied the best in three related peptides; it consists of two linearly exposed sites of A-chain. Composition of the site S-1 A (Phen8, Arg9, Ser10) provides a possibility of binding the ligand with IGF-I-receptor, while the level of affinity to it depends on the composition of S-2. The S-2 A composition (Arg14, Arg15) determines the low affinity of IGF-I to the IGF-II-receptor. The clear functioning of IGF-I and elimination of mixture of functions at the level of the binding activity depend on the spatial autonomy of BD of different nature, difference in structural organization of each of the domains, and a peculiarity of principles of formation of affinity in each case. The spatial coordination of several BD sites is the condition for transmission of the “structural signal“ by regulatory peptide. The performed analysis provides the direct notion of dependence of the binding ability of the IGF-I molecule that has BD of different nature on their structural peculiarities and allows using the revealed regularities at searching for BD in the newly discovered insulinlike peptides.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Smith, A.B., Kesteren, R.E., Li, K.W., van Minen, J., Spijker, S., van Heerikhuizen, H., and Geraerts, W.P.M., Towards Understanding the Role of Insulin in the Brain: Lessons from Insulin-Related Signaling Systems in the Invertebrate Brain, Progr. Neurobiol., 1988, vol. 54, pp. 35–54.

    Article  Google Scholar 

  2. Kolychev, A.P., The Insulin-Related Peptides in Phylogenesis. Binding Capacity of Regulatory Peptides—the Key to Search for Their Functional Role. Introduction to the Problem, Zh. Evol. Biokhim. Fiziol., 2008, vol. 44, pp. 649–664.

    CAS  PubMed  Google Scholar 

  3. Kolychev, A.P., Insulin-Like Growth Factors (IGF) in Vertebrate Phylogenesis. Comparative Analysis of the Structural Peculiarities of IGF-II Domain, Binding with Mannose-6-Phosphate IGF-2-Receptor, Zh. Evol. Biokhim. Fiziol., 2005, vol. 41, pp. 473–489.

    CAS  PubMed  Google Scholar 

  4. Laron, Z., Insulin Like Growth Factor-1 a Growth Hormone, Mol. Pathol., 2001, vol. 54, pp. 311–316.

    Article  CAS  PubMed  Google Scholar 

  5. Schumacher, R., Mostaf, L., Shlessinger, J., Brabdenburg, D., and Ulrich, A., Insulin and Insulin-Like Growth Factor-1 Binding Specificity Is Determined by Distinct Regions of Their Cognate Receptors, J. Biol. Chem., 1991, vol. 266, pp. 19 288–19 298.

    CAS  Google Scholar 

  6. Gammeltoft, S., Insulin Receptors: Binding Kinetics and Structure-Function Relationship of Insulin, Physiol. Rev., 1984, vol. 64, pp. 1321–1378.

    CAS  PubMed  Google Scholar 

  7. Clemmons, D.R., Jones, J.I., Busby, W.H., and Wright, G., Role of Insulin-Like Growth Factor Binding Proteins in Modifying IGF Action, Ann. N.Y. Acad. Sci., 1993, vol. 692, pp. 10–21.

    Article  CAS  PubMed  Google Scholar 

  8. Ballard, E.J., Ross, M., Upton, F.M., and Fransis, G.L., Specific Binding of Insulin-Like Growth Factors 1 and 2 to the Type 1 and Type 2 Receptors, Respectively, Biochem. J., 1988, vol. 249, pp. 732–726.

    Google Scholar 

  9. Baker, J., Liu, J.-P., Robertson, E.J., and Efstratiadis, A., Role of Insulin-Like Growth Factors in Embryonic and Postnatal Growth, Cell, 1993, vol. 75, pp. 73–82.

    CAS  PubMed  Google Scholar 

  10. Liu, J.P., Baker, J., Perkins, A.S., Robertson, E.J., and Efstratiadis, A., Mice Carrying Null Mutations of the Genes Encoding Insulin-Like Growth Factors I (IGF-I) and Type I IGF Receptor (IgfIr), Cell, 1993, vol. 75, pp. 59–72.

    CAS  PubMed  Google Scholar 

  11. Bayne, M.J., Applebaum, J., Chicchi, G.G., Hayes, N.S., Green, B.G., and Cascieri, M.A., Structural Analogs of Human Insulin-Like Growth Factors I with Reduced Affinity for Serum Binding Proteins and the Type 2 Insulin-Like Growth Factor Receptor, J. Biol. Chem., 1988, vol. 263, pp. 6233–6239.

    CAS  PubMed  Google Scholar 

  12. Brzozowski, A.M., Dodson, E.J., Dodson, G.G., Murshudov, G.N., Verma, C., Turkenburg, J.P., de Bree, F.M., and Dauter, Z., Structural Origins of the Functional Divergence of Human Insulin-Like Growth Factor-I and Insulin, Biochemistry, 2002, vol. 41, pp. 9389–9397.

    Article  CAS  PubMed  Google Scholar 

  13. Conlon, M.J., Evolution of Insulin Molecule: Insights into Structure-Activity and Phylogenetic Relationships, Peptides, 2001, vol. 22, pp. 1183–1193.

    Article  CAS  PubMed  Google Scholar 

  14. Kolychev, A.P., Insulin-Like Growth Factor II. The Place among Regulatory Peptides of Insulin Superfamily, Zh. Evol. Biokhim. Fiziol., 2000, vol. 36, pp. 69–82.

    CAS  PubMed  Google Scholar 

  15. Genbank UniProtKB/Swiss-Prot PO1344 (IGF2-HUMAN) / version 129.

  16. Rinderknecht, E. and Humbel, R.E., Primary Structure of Human Insulin-Like Growth Factor-II, FEBS Lett., 1978, vol. 89, pp. 283–286.

    Article  CAS  PubMed  Google Scholar 

  17. Blundell, T.L., Bedarscar, S., and Humbel, R.E., Tertiary Structures, Receptor Binding, and Antigenicity of Insulin-Like Growth Factors, FASEB J., 1983, vol. 42, no. 3, pp. 2592–2597.

    CAS  Google Scholar 

  18. Sato, A., Koyama, S., Yamada, H., Suzuki, S., Kobayashi, M., Niwa, M., Yasuda, T., Kyogoku, Y., and Kobayashi, Y., Three-Dimensional Solution Structure of a Disulfide Bond Isomer of the Human Insulin-Like Growth Factor-I, J. Peptide Res., 2000, vol. 56, pp. 218–230.

    Article  CAS  Google Scholar 

  19. Froesch, E.R., Schmid, C., Schwander, J., and Zapf, J., Action of Insulin-Like Growth Factors, Ann. Rev. Physiol., 1985, vol. 47, pp. 443–467.

    Article  CAS  Google Scholar 

  20. Jones, J.I. and Clemmons, D.R., Insulin-Like Growth Factor and Their Binding Proteins: Biological Actions, Endocr. Rev., 1995, vol. 16, no. 15, pp. 3–34.

    CAS  PubMed  Google Scholar 

  21. Pillak, M.N., Insulin Like Growth Factors and Neoplazia, Biology of IGF-I: Its Interaction with Insulin in Health and Malignant States, Novartis Fuond. Symp., 262, Willey, UK, 2004, pp. 84–97.

  22. LeRoith, D., Adamo, M., Kato, H., and Roberts, C.T., Divergence of Insulin and Insulin-Like Growth-1 Signaling Pathways, Pediatr. Adolesc. Endocrinol. Basel., 1993, vol. 24, pp. 346–358.

    Google Scholar 

  23. Leybuch, B.N., Receptors of Insulin and Insulin-Like Growth Factor-I: Pathways of Structural and Functional Divergence of Two Evolutionary Related Molecules, Zh. Evol. Biokhim. Fiziol., 1998, vol. 34, pp. 82–96.

    Google Scholar 

  24. Ward, C.W., Garrett, T.P.J., McKern, N.M., Lou, M., Cosgrove, L.J., Sparrow, L.G., Frenkel, M.J., Hoyne, P.A., Elleman, T.C., Adams, T.E., Lovrecz, G.O., Lawrence, L.J., and Tulloch, P.A., The Three Dimensional Structure of the Type I Insulin-Like Growth Factor Receptor, Mol. Pathol., 2001, vol. 54, pp. 125–132.

    Article  CAS  PubMed  Google Scholar 

  25. Hwa, V., Oh, Y., and Rosenfeld, R.C., The Insulin-Like Growth-Binding Proteins (IGFBP) Superfamily, Endocr. Rev., 1999, vol. 20, pp. 760–787.

    Article  Google Scholar 

  26. Siwanowich, I., Popowich, G.M., Wisniewska, M., Huber, R., Kuenkele, K.-P., Lang, K., Engh, R.A., and Holak, T.A., Structural Basis for the Regulation of Insulin-Like Growth Factors by IGF Binding Proteins, Structure, 2005, vol. 13, pp. 155–167.

    Article  Google Scholar 

  27. Headey, S.J., Leading, K.S., Norton, R.S., and Bach, L.A., Contributions of the N- and C-Terminal Domains of IGF Binding Protein-6 to IGF Binding, J. Mol. Endocrinol., 2004, vol. 33, pp. 377–386.

    Article  CAS  PubMed  Google Scholar 

  28. Tong, P.Y., Tolefsen, S.E., and Kornfeld, S., The Cation-Dependent Mannose-6-Phosphate Receptor Binds Insulin-Like Growth Factor-II, J. Biol. Chem., 1988, vol. 263, pp. 2585–2588.

    CAS  PubMed  Google Scholar 

  29. Kornfeld, S., Structure and Function of the Mannose-6-Phosphate/Insulin-Like Growth Factor II Receptors, Annu. Rev. Biochem., 1992, vol. 61, pp. 307–330.

    Article  CAS  PubMed  Google Scholar 

  30. Dahms, N.M., Label, P., and Kornfeld, S., Mannose-6-Phosphate Receptors and Lysosomal Enzyme Targeting, J. Biol. Chem., 1989, vol. 264, pp. 12 115–12 118.

    CAS  Google Scholar 

  31. Garmloudi, F. and MacDonald, G.R., Localization of the Insulin Like Growth II (IGF-II) Binding/Cross-Linking Site of the IGF-2/Mannose-6-Phosphate Receptor to Extracellular Repeats 10–11, J. Biol. Chem., 1994, vol. 269, pp. 26 944–26 953.

    Google Scholar 

  32. Jirtle, R.L., Carr, B.I., and Scott, C.D., Modulation of Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptors and Transforming Growth Factor-B1 during Liver Regeneration, J. Biol. Chem., 1991, vol. 266, pp. 22 444–22 450.

    CAS  Google Scholar 

  33. Maly, P. and Luthi, C., The Binding Sites of Insulin-Like Growth Factor-I (IGF-I) to Type I IGF-Receptor and to a Monoclonal Antibodies, J. Biol. Chem., 1988, vol. 263, pp. 7068–7072.

    CAS  PubMed  Google Scholar 

  34. Cara, J., Mirmira, R.G., Nakagawa, S.H., and Tager, H.S., Insulin-Like Growth Factor-I/Insulin Hybrid Exhibiting High Potency for Interaction with the Type I Insulin-Like Growth Factor and Insulin Receptors of Placental Plasma Membranes, J. Biol. Chem., 1990, vol. 263, pp. 17 820–17 825.

    Google Scholar 

  35. Tseng, L.Y.-H., Shwartz, G.P., Sheikh, M., Chen, Z.Z., Joshi, S., Wang, J.-W., Nissley, S.P., Burke, T., Katsoyannis, P.G., and Rechler, M.M., Hybrid Molecules Containing the A-Domain of Insulin-Like Growth Factor I and B-Chain of Insulin Have Increased Mitogenic Activity Relative to Insulin, BBRC, 1987, vol. 149, pp. 672–679.

    CAS  PubMed  Google Scholar 

  36. King, C.L. and Kahn, C.R., Synthesis and Characterization of Molecular Hybrids if Insulin and Insulin-Like Growth Factor-I, J. Biol. Chem., 1982, vol. 257, pp. 10 869–10 873.

    CAS  Google Scholar 

  37. Cascieri, M.A., Chiechi, G.G., Applebaum, J., Hayes, N.S., Green, B.G., and Bayne, M.L., Mutants of Insulin-Like Growth Factor I with Reduced Affinity for the Type I Insulin-Like Growth Factor Receptor, Biochemistry, 1988, vol. 27, pp. 3229–3233.

    Article  CAS  PubMed  Google Scholar 

  38. Kobayashi, M., Ohgako, S., Iwasaki, M., Maegawa, H., Shigeta, Y., and Inouye, K., Characterization of [LeuB-24] and [LeuB-25] Insulin Analogues, Biochem. J., 1982, vol. 206, pp. 597–603.

    CAS  PubMed  Google Scholar 

  39. Tager, H.S., Thowas, N., Assoian, R., Rubinstein, A., Saekow, M., Olefsky, J., and Kaizer, E.T., Semisynthesis and Biological Activity of Porcine (LeuB24) and (LeuB25)Insulin, Proc. Natl. Acad. Sci., 1980, vol. 72, pp. 3181–3185.

    Article  Google Scholar 

  40. Burgisser, D.M., Roth, B.V., Giger, R., Luthi, C., Weigl, S., Zaru, J., and Humbel, R.E., Mutants of Human Insulin-Like Growth Factor-II with Altered Affinities for the Type I and Type 2 Insulin-Like Growth Factor Receptors, J. Biol. Chem., 1991, vol. 266, pp. 1029–1033.

    CAS  PubMed  Google Scholar 

  41. Hodgson, D.R., May, F.E.B., and Westley, B.R., Involvement of Phenylalanine 23 in the Binding of IGF-I to the Insulin and Type I IGF Receptor, Regulat. Peptides, 1996, vol. 22, pp. 191–196.

    Article  Google Scholar 

  42. Wollmer, A., Strassburger, W., Glatter, U., Dodson, G.G., McCail, M., Gattner, H.-G., Danbo, W., and Branderburg, D., Two Mutant Forms of Human Insulin. Structural Consequences of Substitution of Invariant B24 or B25-Phenylalanine by Leucine, Hoppe-Seyler’s Z. Physiol. Chem., 1981, vol. 362, pp. 581–591.

    CAS  PubMed  Google Scholar 

  43. Cara, J.F., Nakagawa, S.H., and Tager, H.S., Structural Determinants of Ligand Recognition by Type I Insulin-Like Growth Receptors: Use of Semisynthetic Insulin Analog Probes, Endocrinol., 1988, vol. 122, pp. 2881–2886.

    Article  CAS  Google Scholar 

  44. Bayne, M.L., Applebaum, J., Underwood, D., Chiechi, G.G., Green, B.G., Hayes, N.S., and Cascieri, M.A., The C-Region of Human Insulin-Like Growth Factor (IGF) I is Required for High Affinity Binding to the Type I IGF Receptor, J. Biol. Chem., 1989, vol. 264, pp. 11 004–11 008.

    CAS  Google Scholar 

  45. Hua, Q.-X., Hu, S.-Q., Jia, W., Chu, Y.-C., Burke, G.T., Wang, S.-H., Wang, R.-Y., Katsoyannis, P.G., and Wiess, A.M., Mini-Proinsulin and Mini-IGF-I: Homologous Protein Sequence Encoding Non-Homologous Structures, J. Mol. Biol., 1998, vol. 277, pp. 103–118.

    Article  CAS  PubMed  Google Scholar 

  46. Bayne, M.L., Applebaum, J., Chiechi, G.G., Miller, R.E., and Cascieri, M.A., The Role of the Tyrosines 24, 31 and 60 in the High Affinity Binding of Insulin-Like Growth Factor Receptor, J. Biol. Chem., 1990, vol. 265, pp. 15 648–15 652.

    CAS  Google Scholar 

  47. Forbes, B.E., Hartfield, P.J., McNeil, K.A., Surinya, K.Y., Milner, S.J., Cosgrovel, J., and Wallace, J., Characteristics of Minding of Insulin-Like Growth Factor (IGF)-I and IGF-II Analogues to the Type I IGF Receptor Determined by BIAcore Analysis, Eur. J. Biochem., 2002, vol. 269, pp. 961–958.

    Article  CAS  PubMed  Google Scholar 

  48. Milmer, S.J., Francis, G.L., Wallace, J.C., Magee, B.A., and Ballard, E.J., Mutations in the B-Chain of Insulin-Like Growth Factor-I Influence the Oxidative Folding to Yield Products with Modified Biological Properties, Biochem. J., 1995, vol. 308, pp. 865–871.

    Google Scholar 

  49. Cascieri, M.A., Chicchi, G.G., Applebaum, J., Green, B.G., Hayes, N.S., and Bayne, M.J., Structural Analogs of Human Insulin-Like Growth Factor (IGF) I with Altered Affinity for the Type 2 IGF Receptor, J. Biol. Chem., 1989, vol. 264, pp. 2199–2202.

    CAS  PubMed  Google Scholar 

  50. Rosenfeld, R.G., Conover, D., Hodges, P.D.K., Lee, P., Hintz, R.L., and Li, C.H., Heterogeneity of Insulin-Like Growth Factor-I Affinity for the Insulin-Like Growth Factor II Receptor: Comparison of Natural, Synthetic and Recombinant DNA-Derived Insulin-Like Growth Factor-I, BBRC, 1987, vol. 143, pp. 199–205.

    CAS  PubMed  Google Scholar 

  51. Shooter, G.K., Magee, B., Soos, M.A., Francis, G.L., Siddle, K., and Wallace, J.C., Insulin-Like Growth Factor (IGF)-I A- and B-Domain Analogues with Altered Type I IGF and Insulin Receptor Binding Specificities, J. Mol. Endocr., 1996, vol. 17, pp. 237–246.

    Article  CAS  Google Scholar 

  52. Denly, A., Wang, C.C., McNeil, K.A., Walenkamp, M.J.E., van Duyvenvoorde, H., Wit, J.M., Wallace, J.C., Norton, R.S., Karperien, M., and Forbes, B.E., Structural and Functional Characteristics of the Val44Met Insulin-Like Growth Factor-I Missense Mutation: Correlation with Effects on Growth and Development, Mol. Endocrin., 2005, vol. 19, pp. 711–721.

    Article  Google Scholar 

  53. Oh, Y., Beukers, M.W., Pham, H.M., Smanik, P.A., Smith, M.C., and Rosenfeld, R.G., Altered Affinity of Insulin-Like Growth Factor-II (IHG-II) for Receptors and IGF-Binding Proteins, Resulting from Limited Modifications of the IGF-II Molecule, Biochem. J., 1991, vol. 278, pp. 249–254.

    CAS  PubMed  Google Scholar 

  54. Bach, L.A., Hsien, S., Sacano, K.-I., Fuyiwara, H., Perdue, F.J., and Rechler, M.M., Binding of Mutants of Human Insulin-Like Growth Factor II to Insulin-Like Growth Factor Proteins 1–6, J. Biol. Chem., 1992, vol. 268, pp. 9246–9254.

    Google Scholar 

  55. Magee, B.A., Shooter, G.K., Wallace, J.C., and Franciz, G.L., Insulin-Like Growth Factor-I and Its Binding Proteins: a Study of the Binding Interface Using B-Domain Analogues, Biochemistry, 1999, vol. 38, pp. 15 863–15 870.

    Article  CAS  Google Scholar 

  56. Cascieri, M.A., Hayes, N.S., and Bayne, M.J., Characterization of the Increased Biological Potency in BALB/C 3T3 Cells of Two Analogs of Human Insulin-Like Growth Factor-I Which Have Reduced Affinity for the 28 K Cell-Derived Binding Protein, J. Cell Physiol., 1989, vol. 139, pp. 181–188.

    Article  CAS  PubMed  Google Scholar 

  57. Francis, G.L., Upton, F.M., Ballard, F.J., McNeil, K.A., and Wallace, J.C., Insulin-Like Growth Factors I and 2 in Bovine Colostrum, Biochem. J., 1988, vol. 251, pp. 95–103.

    CAS  PubMed  Google Scholar 

  58. Ross, M., Francis, G.L., Szabo, L., Wallace, J.C., and Ballard, F.J., Insulin-Like Growth Factor (IGF)-Binding Proteins Inhibit Biological Activities of IGF-I and IGF-2 but not Des-(1–3)-IGFI, Biochem. J., 1989, vol. 258, pp. 267–272.

    CAS  PubMed  Google Scholar 

  59. Bagley, C.J., May, B.L., Szabo, L., McNamara, P.J., Ross, M., Francis, G.L., Ballard, F.J., and Wallace, J.C., A Key Functional Role for the Insulin-Like Growth Factor-I N-Terminal Pentapeptide, Biochem. J., 1989, vol. 259, pp. 665–671.

    CAS  PubMed  Google Scholar 

  60. King, R., Wells, J.R., Krieg, P., Snoswell, M., Brazier, J., Bagley, C.J., Wallace, J.C., Ballard, F.J., Ross, M., and Francis, G.L., Production and Characterization of Recombinant Insulin-Like Growth Factor I (IGF-I) and Potent Analogues of IGF-I, with Gly or Arg Substituted for Glu-3, Following Their Expression in Escherichia coli as Fusion Proteins, J. Mol. Endocrin., 1992, vol. 8. pp. 29–41.

    Article  CAS  Google Scholar 

  61. Mendez, E., Planas, J.V., Castillo, J., Navarro, I., and Gutlerrez, J., Identification of a Type II Insulin-Like Growth Factor Receptor in Fish Embryo, Endocrinology, 2001, vol. 264, pp. 1090–1097.

    Article  Google Scholar 

  62. Moss, J.S., Francis, G.L., Ross, M., Wallace, J.C., and Ballard, F.J., Insulin-Like Growth Factor (IGF)-I and IGF-II Binding to an IGF Binding Protein. An Investigation Using Chemical Modification of Tyrosine Residues as a Structural Probe for the Sites of Interaction, J. Biol. Chem., 1991, vol. 266, pp. 909–914.

    CAS  PubMed  Google Scholar 

  63. Sakano, K.-J., Enjoh, T., Namata, F., Fujiwara, F., Marumoto, Y., Higashihashi, N., Sato, Y., Perdue, J.F., and Fujita-Yamaguchi, Y., The Design, Expression, and Characterization of Human Insulin-Like Growth Factor-II (IGF-II) Mutants Specific for either the IGF-II/Cation-Independent Mannose-6-Phosphate Receptor or IGF-I Receptor, J. Biol. Chem., 1991, vol. 266, pp. 20 626–20 635.

    CAS  Google Scholar 

  64. Clemmons, D.R., Cascieri, M.A., Camacho-Hubner, C., McCusker, R.H., and Bayne, M.J., Discrete Alterations of the Insulin-Like Growth Factor-I Molecule Which Alter its Affinity for Insulin-Like Growth Factor-Binding Proteins Result in Change in Bioactivity, J. Biol. Chem., 1990, vol. 265, pp. 12 210–12 216.

    CAS  Google Scholar 

  65. Carric, F.E., Hinds, M.G., McNeil, K.A., Wallace, J.C., Forbes, B.E., and Norton, R.S., Interaction of Insulin-Like Growth Factor (IGF-I and II with IGF Binding Protein-2: Mapping the Binding Surfaces by Nuclear Magnetic Resonance, J. Mol. Endocrin., 2005, vol. 34, pp. 685–698.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia

    A. P. Kolychev

Authors
  1. A. P. Kolychev
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Original Russian Text © A. P. Kolychev, 2010, published in Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, 2010, Vol. 46, No. 1, pp. 74–94.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kolychev, A.P. Structural organization of binding determinants in the molecule of insulin-like growth factor-I (IGF-I). J Evol Biochem Phys 46, 87–112 (2010). https://doi.org/10.1134/S002209301001010X

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S002209301001010X

Key words

Search

Navigation